Otsuka Pakistan Ltd

Otsuka Pakistan Ltd operates with a debt-to-equity ratio of 1.37, indicating a moderate reliance on debt financing relative to equity. The company's liquidity position is assessed as medium, with a current ratio of 1.08, suggesting it has just enough current assets to cover its short-term liabilities. However, the company's free cash flow is negative at -34.84 million PKR, and its operating cash flow is 68.10 million PKR, indicating that while it generates positive cash from operations, capital expenditures are consuming more than that.

Profitability metrics show a return on equity (ROE) of -2.07% and a return on assets (ROA) of -0.61%, both of which are negative and significantly below the typical performance of the pharmaceutical industry. These figures suggest that the company is not generating returns for its shareholders or effectively utilizing its assets to generate profit.

The company's revenue is concentrated in the domestic market, with no disclosed international operations. This geographic concentration increases exposure to local economic and regulatory risks. The company's revenue of 566.40 million PKR is derived from a single business segment, which is the pharmaceuticals division. There is no indication of diversification into other therapeutic areas or product lines.

Looking at the growth trajectory, the company's recent financial performance shows a net loss of 14.58 million PKR, and there is no disclosed revenue growth or expansion into new markets. The capital expenditure of -111.70 million PKR indicates a significant investment in infrastructure or equipment, which may be a precursor to future growth. However, the negative net income and lack of disclosed revenue growth suggest that the company is not currently expanding its market share or increasing its profitability.

The risk assessment highlights a key flag: the company has negative net cash after subtracting total debt, which could indicate liquidity stress. The dilution risk is assessed as low, with no near-term pressure from share issuance or dilutive events. The company's liquidity risk is moderate, and its credit risk is not explicitly stated but inferred from the debt-to-equity ratio and negative net cash position.

Recent events include the company's latest financial filing, which discloses the financial snapshot and valuation metrics. There are no recent transcripts or press releases indicating significant operational or strategic changes. The company's financial performance and risk profile suggest a need for close monitoring of its liquidity and profitability trends.

Net income surged 681.1% year-over-year to PKR 27.7 million, signaling a strong operational turnaround.

Revenue grew 19.5% year-over-year to PKR 3.78 billion, demonstrating robust top-line expansion momentum.

Operating income increased 33.8% year-over-year to PKR 162.9 million, reflecting improved core business profitability.

Long-term debt decreased significantly from PKR 1.08 billion to PKR 405 million over the four-year period.

Gross profit reached PKR 863.4 million in the latest period, maintaining a healthy margin above operating costs.

The company carries a high credit risk flag, indicating significant potential for financial distress or default.

Debt-to-equity ratio of 1.37 is in the bottom quartile, indicating excessive leverage compared to peers.